Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG: 2196)

Shanghai Fosun Pharmaceutical (Group) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13,508	13,694	16,241	10,317	9,962	9,533
Trading Asset Securities	2,122	1,888	928.53	4,241	1,970	456.65
Cash & Short-Term Investments	15,630	15,582	17,170	14,558	11,932	9,990
Cash Growth	-1.12%	-9.25%	17.94%	22.01%	19.44%	9.03%
Accounts Receivable	9,118	8,457	8,172	6,474	5,436	5,053
Other Receivables	701.7	636.27	611.57	875.26	357.09	442.75
Receivables	9,820	9,093	8,783	7,538	5,793	5,496
Inventory	7,435	7,538	6,882	5,473	5,163	3,941
Other Current Assets	1,642	1,580	2,443	2,868	2,197	977.34
Total Current Assets	34,527	33,793	35,279	30,437	25,085	20,403
Property, Plant & Equipment	21,861	22,239	16,028	13,284	13,003	11,085
Long-Term Investments	25,889	25,012	25,549	23,920	23,771	23,021
Goodwill	10,801	10,852	10,337	9,400	8,677	9,014
Other Intangible Assets	13,032	13,482	12,471	10,276	8,670	7,916
Long-Term Accounts Receivable	-	83.01	91.66	77.4	-	-
Long-Term Deferred Tax Assets	791.14	624.47	442.57	265.59	244.94	196.09
Long-Term Deferred Charges	5,950	4,675	4,008	3,632	3,152	3,211
Other Long-Term Assets	2,414	2,512	2,836	2,014	894.88	1,085
Total Assets	115,265	113,470	107,164	93,306	83,686	76,120
Accounts Payable	6,342	6,160	6,284	5,064	3,289	2,397
Accrued Expenses	1,683	5,414	5,577	4,807	4,234	3,849
Short-Term Debt	18,680	14,728	11,932	10,629	7,916	6,358
Current Portion of Long-Term Debt	5,005	4,422	5,230	4,986	6,771	2,418
Current Portion of Leases	-	329.53	184.41	141.5	151.08	143.79
Current Income Taxes Payable	537.02	250.63	619.34	474.22	325.43	452.59
Current Unearned Revenue	1,007	1,200	1,545	1,154	1,020	511.22
Other Current Liabilities	4,264	1,253	1,928	2,063	1,165	1,304
Total Current Liabilities	37,518	33,758	33,298	29,318	24,872	17,434
Long-Term Debt	8,870	13,505	12,100	9,049	8,476	12,577
Long-Term Leases	2,217	2,050	744.99	648.36	627.29	410.19
Long-Term Unearned Revenue	605.08	959.18	986.85	751.82	603.91	640.35
Long-Term Deferred Tax Liabilities	3,465	3,445	3,363	3,130	2,853	2,994
Other Long-Term Liabilities	3,395	3,137	2,562	2,029	269.49	2,860
Total Liabilities	56,070	56,853	53,055	44,927	37,702	36,915
Common Stock	2,671	2,672	2,672	2,563	2,563	2,563
Additional Paid-In Capital	-	16,853	16,992	14,041	15,133	12,144
Retained Earnings	28,786	27,501	26,170	23,858	20,234	17,650
Treasury Stock	-206.9	-41.93	-53.25	-	-	-
Comprehensive Income & Other	16,051	-1,300	-1,198	-1,266	-933.58	-467.99
Total Common Equity	47,301	45,685	44,582	39,196	36,996	31,888
Minority Interest	11,893	10,931	9,526	9,184	8,989	7,316
Shareholders' Equity	59,195	56,616	54,109	48,380	45,984	39,204
Total Liabilities & Equity	115,265	113,470	107,164	93,306	83,686	76,120
Total Debt	34,772	35,035	30,191	25,454	23,941	21,908
Net Cash (Debt)	-19,142	-19,453	-13,021	-10,896	-12,009	-11,918
Net Cash Per Share	-7.12	-7.29	-4.99	-4.25	-4.69	-4.65
Filing Date Shares Outstanding	2,660	2,672	2,672	2,563	2,563	2,563
Total Common Shares Outstanding	2,660	2,672	2,672	2,563	2,563	2,563
Working Capital	-2,990	34.99	1,981	1,118	212.45	2,970
Book Value Per Share	17.78	17.10	16.68	15.29	14.44	12.44
Tangible Book Value	23,469	21,351	21,774	19,519	19,649	14,958
Tangible Book Value Per Share	8.82	7.99	8.15	7.62	7.67	5.84
Land	-	951.74	201.31	203.68	196.58	188.04
Buildings	-	11,471	7,733	6,605	6,359	5,796
Machinery	-	14,026	10,700	9,197	8,270	7,368
Construction In Progress	-	4,938	4,897	3,618	4,122	3,150

Source: S&P Capital IQ. Standard template. Financial Sources.